Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,446 total articles
Agora, Inc., a leader in conversational AI and real-time engagement technology, announced that its CEO Tony Zhao intends to invest up to $20 million in the company’s shares over the next 12 months. This management share purchase plan aims to demonstrate confidence in the company's growth prospects amid expanding market opportunities in real-time en…
Immatics N.V. presented extended Phase 1b clinical trial data for its anzu-cel (IMA203) PRAME-targeted TCR T-cell therapy at the 2026 ASCO Annual Meeting, showing rapid, deep, and durable anti-tumor responses in heavily pretreated metastatic melanoma patients, including cutaneous and uveal subtypes. The therapy demonstrated a 56% confirmed overall …
Viasat Inc. has been selected by Lockheed Martin to supply high-bandwidth satellite communications technology for NOAA’s next-generation C-130J 'Hurricane Hunter' aircraft. This contract involves delivering Viasat's Hybrid SATCOM Approach technology to enable resilient, real-time data transmission supporting hurricane forecasting and severe weather…
zSpace, Inc., a provider of immersive augmented and virtual reality learning technology, announced it has converted more than $12 million of its outstanding debt into equity through agreements with lenders. This transaction eliminates related debt obligations, thus improving the company's financial foundation and enabling focus on its growth in edu…
Senseonics Holdings announced plans for an analyst event and an oral presentation at the upcoming ADA 2026 Scientific Sessions to showcase recent commercial milestones and new real-world evidence for their implantable Eversense 365 Continuous Glucose Monitoring system. These events will focus on the system's performance, integration with insulin pu…
OpenPayd has announced a definitive business combination with Titan Acquisition Corp. to become a publicly traded company on Nasdaq under the ticker OP. Valued at $1.145 billion on a pro-forma basis, OpenPayd operates a global financial infrastructure platform bridging traditional finance with digital assets, including stablecoins, via a single API…
Jasper Therapeutics, a clinical-stage biotech company focused on developing briquilimab for mast cell driven diseases, announced its Board of Directors will evaluate various strategic alternatives including asset sales, collaborations, merger, or wind-down, aiming to maximize shareholder value amid current market challenges. The company continues t…
Ten-League International Holdings Limited, a Singapore-based turnkey project solutions provider, announced it has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share. Following a Nasdaq Hearings Panel review, the company was granted continued listing conditioned upon demonstrating compliance, which it has now achieved…
Vertex, Inc., a leader in enterprise compliance technology, will present at the 46th Annual William Blair Growth Stock Conference to discuss its AI-powered tax automation solutions that help global enterprises manage complex tax processes efficiently. The presentation aims to highlight the company's expertise and growth strategy in the compliance t…
STEALTHGAS INC., a ship-owning company serving the international liquefied petroleum gas (LPG) shipping sector, announced it will release its first quarter 2026 financial and operating results on June 5, 2026. The company will host a conference call and webcast to discuss the results and outlook.
NextCure presented promising Phase 1 dose escalation data for SIM0505, a novel anti-CDH6 antibody-drug conjugate targeting platinum-resistant ovarian cancer (PROC) and uterine serous carcinoma (USC). The study reported a 55% overall response rate in gynecologic cancers, with favorable safety and tolerability profiles. These results support ongoing …
Voyager Therapeutics announced FDA clearance of its Investigational New Drug (IND) application for VY1706, the company's gene therapy targeting tau protein to treat Alzheimer's disease (AD). This first-of-its-kind therapy uses an intravenous brain-targeted capsid to reduce tau production, with clinical dosing expected in the second half of 2026. Pr…
Amneal Pharmaceuticals, a diversified biopharmaceutical company specializing in affordable and innovative medicines, announced that Co-CEO Chirag Patel will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. The presentation will be webcast live and provide insights into the company's diverse portfolio and growth…
Elicio Therapeutics announced the publication of a peer-reviewed study in Science Advances detailing the potent immune responses generated by their novel AMP-DNA adjuvant platform. The preclinical research highlights superior efficacy, durable T cell activation, and a distinct lymph node-targeted mechanism, reinforcing the versatility and potential…
Aura Biosciences announced the completion of enrollment for 108 patients in its pivotal Phase 3 CoMpass trial testing belzupacap sarotalocan (bel-sar) as a frontline, vision-preserving treatment for early choroidal melanoma. Topline data from the 15-month primary endpoint are anticipated in the second half of 2027, marking a key milestone toward po…
Bitdeer Technologies Group announced the launch of the SEALMINER DL1 Hydro, a new hydro-cooled mining machine optimized for the Scrypt algorithm. The device achieves a hashrate of 52.5 GH/s with an energy efficiency of 149 J/GH, supporting coins like Litecoin and Dogecoin. The hydro-cooling design aims to improve operational stability and power eff…
Willis Towers Watson (NYSE: WTW) announced the addition of Alex Holderness and Tim Oliver to its North America Outsourcing Sales team effective June 1, 2026. Both hires bring over 30 years of industry experience in benefits administration, healthcare navigation, and strategic sales leadership. This move aligns with WTW's continued investment in exp…
Geron Corporation announced its participation at the Goldman Sachs 47th Annual Global Healthcare Conference, where management will discuss their commercial-stage biopharmaceutical developments, including the approved telomerase inhibitor RYTELO® (imetelstat) and ongoing Phase 3 clinical trials for hematologic malignancies.
Enlivex Ltd. announced that its Phase IIa clinical trial data for Allocetra, an immunotherapy targeting moderate-to-severe knee osteoarthritis, will be presented at the EULAR 2026 congress. The data show durable and statistically significant improvements in pain reduction and function over 6 months versus placebo. These findings support the ongoing…
House of Doge, the corporate arm of the Dogecoin Foundation and merger partner with Brag House Holdings (NASDAQ:TBH), announced a strategic partnership with Paxos to integrate Dogecoin (DOGE) into Paxos' regulated crypto brokerage and custody platform. This integration will make Dogecoin accessible to hundreds of millions of users via Paxos' enterp…
Genius Group Limited (NYSE: GNS) announced an investor call to discuss its new AI Treasury and AGI Infinity Portfolio, initiating up to $100 million investment focusing on pre-IPO stakes in prominent frontier AI companies such as SpaceX, OpenAI, Anthropic, and Figure AI. The Company outlined a five-year plan to expand the portfolio up to $800 milli…
Caring Brands Inc. and SanPellegrino Cosmetics Private Limited have expanded their multi-territory licensing agreement for Photocil and Hair Enzyme Booster. The revised five-year agreement broadens the commercial reach to include India, LATAM, Russia, Australia, and New Zealand. Both products have demonstrated strong clinical acceptance and commerc…
GT Biopharma announced successful integration of AI-based tools in their drug discovery process, enhancing the identification and engineering of tumor-targeting engagers and multi-domain proteins. This technological advancement is expected to shorten development timelines, reduce costs, and increase the likelihood of clinical success. The company a…
Silicon Valley Acquisition Corp., a Nasdaq-listed SPAC focusing on high-growth sectors, has appointed Melbourne Capital Group as its strategic advisor. This partnership aims to enhance Silicon Valley's access to high-quality opportunities in Asia-Pacific markets. The collaboration leverages Melbourne Capital's strong regional presence and Silicon V…
Rapid7, a leader in AI-powered managed cybersecurity operations, appointed Wael Mohamed as CEO, transitioning founder Corey Thomas to Executive Chairman, while reaffirming its financial guidance for 2026. The leadership change aims to accelerate growth in the AI-SOC market, supported by strategic acquisitions and an expanded senior leadership team …
